Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Feb 27, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how effective a specific type of therapy called group Cognitive Behavioral Therapy (CBT) is for adults who have both Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders (SUDs). Many people with ADHD also struggle with substance use, which can lead to serious health and social problems. The goal of the study is to see if this special group therapy can help improve the lives of those dealing with both conditions.

To be eligible for the trial, participants need to be 18 years or older, currently receiving treatment for a substance use disorder (except tobacco), and diagnosed with ADHD. They should also be able to understand and communicate in French and provide consent to participate. Those who join the study can expect to take part in group therapy sessions, where they will learn skills to manage their ADHD and substance use together. It's important to note that this trial is not currently recruiting participants, so if someone is interested, they will need to wait until the study begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 or older ;
• • Suffer from at least one moderate to severe SUD regarding the DSM-5 (tobacco excluded) ;
• • Being currently treated for a SUD by a physician of a psychologist ;
• • Being diagnosed with an ADHD according to the DIVA 2.0 of DIVA-5 ;
• • Being affiliated to a health insurance ;
• • Understanding and being able to express himselves in French
• • Signed consent
• Exclusion Criteria:
• • Age under 18;
• • Pregnant or breastfeeding women;
• • Not having sign the consent form;
• • Major difficulties in understanding and/or expressing themselves in french;
• • Severe cognitive impairment;
• • Acute medical condition making assessment impossible and/or contraindicating participation in group intervention;
• • Substance use disorder in a protected environment, currentlu or in the last 15 days, or expected during the study;
• • No substance use disorder other than tobacco use disorder;
• • Persons under guardianship;
• • Participant deprived of liberty or under penal care orders;
• • Participation in another group psychotherapeutic intervention throughout the duration of the intervention